Taiwan's HanchorBio teams up with InxMed Shanghai to expand value of lead oncology asset

Taiwan-based HanchorBio, Inc. is taking another step to broaden the development path for HCB101, its lead oncology asset...

July 9, 2026 | Thursday | News
Australia's breakthrough in search for Motor Neurone Disease treatment

Australia-based University of Queensland (UQ) researchers have developed a drug that activates a hard-to-target immune r...

July 8, 2026 | Wednesday | News
The Manufacturing Shift Powering In Vivo Gene Therapy

The rapid expansion of in vivo gene therapy is reshaping expectations for viral vector manufacturing, placing greater em...

July 5, 2026 | Sunday | Influencers
MIT- Koch Institute to advance AI-driven cancer research in Abu Dhabi

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, and US-based MI...

July 3, 2026 | Friday | News
Eppendorf Research 3 neo pipette wins two international awards

Eppendorf has announced that its Eppendorf Research 3 neo mechanical pipettes have received two major international awar...

July 3, 2026 | Friday | News
Sanyou Bio and Baiyunshan Xihe join forces to advance innovative radiopharma and radiodiagnostics

China-based Sanyou Biopharmaceutical and Guangzhou Baiyunshan Xihe Health Pharmaceutical have jointly announced the offi...

July 6, 2026 | Monday | News
Anixa Biosciences secures Korean patent for breast cancer vaccine

US-based biotech company Anixa Biosciences has announced that the Korean Ministry of Intellectual Propert...

June 30, 2026 | Tuesday | News
China-based CanSinoBIO's meningococcal polysaccharide conjugate vaccine receives registration approval in Argentina

China-based CanSino Biologics Inc. has announced that the company's ACYW135 Meningococcal Polysaccharide Conjugate Vacci...

June 30, 2026 | Tuesday | News
Taiwan Leapfrogs Biomedicine Growth

Taiwan's 5+2 Industrial Innovation Plan was launched as a national initiative to transform the country from an efficienc...

July 1, 2026 | Wednesday | Analysis
Japan's Nippon Shinyaku partners with Elixirgen to develop drug for Duchenne Muscular Dystrophy treatment

Japan-based Nippon Shinyaku has entered into an option agreement with US-based Elixirgen Therapeutics, Inc. under which ...

June 29, 2026 | Monday | News
Mubadala Bio partners with Biosidus to advance access to biologic therapies in UAE

Mubadala Bio has announced the signing of a licencing and supply agreement with Biosidus, a leading biotechnology compan...

June 26, 2026 | Friday | News
NeuroSense reports Phase 2 biomarker findings for PrimeC in Alzheimer’s disease

NeuroSense Therapeutics has reported positive biomarker findings from its Phase 2 RoAD proof-of-concept study of PrimeC ...

June 26, 2026 | Friday | News
ATLATL and Samsung Bioepis to accelerate early-stage biotech innovation across Asia-Pacific

China-based ATLATL Innovation Center, a global innovation platform for life science research and development, and Korea'...

June 25, 2026 | Thursday | News
Ollin raises $330M to advance Phase III retinal disease programme

Ollin Biosciences has completed an oversubscribed US$330 million Series B financing to advance global Phase III developm...

June 25, 2026 | Thursday | News
Innovent doses first patient in Phase III tri-specific antibody trial

Innovent Biologics has dosed the first patient in the Chinese pivotal Phase III TriadicMM-1 trial of IBI3003 for relapse...

June 25, 2026 | Thursday | News
Asia’s biotech innovation gains momentum as funding models become increasingly relevant

  As biotech innovation accelerates, Asia emerges as an increasingly important hub, driv...

June 25, 2026 | Thursday | Opinion
Cincinnati Is Accelerating the Next Wave of Life Sciences Innovation Through Collaboration

Cincinnati's life sciences ecosystem is gaining momentum through a unique combination of scientific excellence, collabor...

June 25, 2026 | Thursday | Influencers
Policy, Talent and Innovation Are Fueling Pennsylvania's Life Sciences Growth

During BIO 2026 in San Diego, BioSpectrum Asia spoke with Kurt Imhof, Senior Vice President, Policy & Public Affairs...

June 25, 2026 | Thursday | Influencers
Creating the Next Generation of Life Sciences Growth in Central Texas

During the BIO International Convention 2026 (June 22–25) in San Diego, BioSpectrum Asia spoke with Arthur Jackson...

June 25, 2026 | Thursday | Influencers
NVIDIA Announces BioNeMo Agent Toolkit

NVIDIA announced NVIDIA BioNeMo Agent Toolkit, which provides domain-specific tools and skills for the agentic life scie...

June 24, 2026 | Wednesday | News
Oral GLP-1s Could Redefine the Next Phase of Cardiometabolic Care

As obesity treatment evolves beyond weight loss toward comprehensive cardiometabolic disease management, pharmaceutical ...

June 24, 2026 | Wednesday | Influencers
Palmer Holland partners FerrinX to distribute precision-fermented lactoferrin

Palmer Holland has partnered with FerrinX to distribute NanoFerrin, a precision-fermented form of lactoferrin for skinca...

June 24, 2026 | Wednesday | News
Abu Dhabi, Biocom California form life sciences corridor

The Department of Health – Abu Dhabi and Biocom California have announced a strategic partnership to create a form...

June 24, 2026 | Wednesday | News
Why the Fight Against Antimicrobial Resistance Must Include Fungal Infections

While antimicrobial resistance (AMR) is often overshadowed by high-profile therapeutic areas such as oncology, its growi...

June 23, 2026 | Tuesday | Influencers
AnHorn secures US and Taiwan regulatory milestones for CIPN candidate

AnHorn Medicines has received U.S. FDA Investigational New Drug clearance and Taiwan Center for Drug Evaluation Index Ca...

June 23, 2026 | Tuesday | News